In summary
Manufacturing:
- Independent Qualified Person Audit completed successfully of Peptrons manufacturing facility
- Initial purchase order places. Batches produced and in storage awaiting dispatch to clinical sites once these are opened.
Phase 3 Trial Preparation
- Successfully filed CTA to commence in Australia, now awaiting approval. Sites are planned
- Needs to file still with UK, Europe and US (anticipates completion 1H CY 2022 (Jan 22 to Jun 22)
Rebates
- Further rebates anticipated with commencement trials
Payments to Related Parties
Kind of pushes the timeline out here IMO. Thought wed commence trials in April/May but looks like we might not even finish filing with regulative authorities till June 2022.
In summaryManufacturing:- Independent Qualified Person Audit...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.237M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28352 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 8998 | 1 |
View Market Depth
| Last trade - 16.21pm 28/07/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable